TALIS BIOMEDICAL CORP (TLIS) Institutional Ownership

TLIS is currently held by 1 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $1.11M based on the latest available SEC Form 13F filings for the quarter ended December 31, 2023.

The largest disclosed holder is Greenlight Capital, which reported ownership valued at approximately $1.11M in its December 31, 2023 13F filing.

Major shareholders tracked on this page include Greenlight Capital, and other prominent asset managers. Collectively, these investors account for approximately 100% of the total disclosed value among the investors covered in this analysis.

This page tracks 13F-reported ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance to help investors analyze smart money sentiment toward TALIS BIOMEDICAL CORP (TLIS).